Tanase et al.24 found that overexpression of caveolin-1 correlates with tumor progression biomarkers, such as TP53 mutation and CA19-9 level, in PDAC, suggesting that specific driver-gene mutations might regulate the cavin-1/caveolin-1 axis. Here, CAVIN1 is linked to neoplasm.